Cited by 2,969Hematopoietic Stem Cell TransplantationInflammatory Biomarkers in Disease PrognosisRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Open access

Sorror, Mohamed L., Maris, Michael B., Storb, Rainer, Baron, Frederic, Sandmaier, Brenda M., Maloney, David G., Storer, Barry·2005·Blood

DOI 10.1182/blood-2005-05-2004PMC PMC1895304

Open this paper in CoChat — free account Open PDF

Abstract

We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT). However, the sample size of patients with scores of 1 or more, captured by the CCI, did not exceed 35%. Further, some comorbidities were rarely found among patients who underwent HCT. Therefore, the current study was designed to (1) better define previously identified comorbidities using pretransplant laboratory data, (2) investigate additional HCT-related comorbidities, and (3) establish comorbidity scores that were suited for HCT. Data were collected from 1055 patients, and then randomly divided into training and validation sets. Weights were assigned to individual comorbidities according to their prognostic significance in Cox proportional hazard models. The new index was then validated. The new index proved to be more sensitive than the CCI since it captured 62% of patients with scores more than 0 compared with 12%, respectively. Further, the new index showed better survival prediction than the CCI (likelihood ratio of 23.7 versus 7.1 and c statistics of 0.661 versus 0.561, respectively, P < .001). In conclusion, the new simple index provided valid and reliable scoring of pretransplant comorbidities that predicted nonrelapse mortality and survival. This index will be useful for clinical trials and patient counseling before HCT. (Blood. 2005;106: 2912-2919)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2005-05-2004

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Regression modelling strategies for improved prognostic prediction
Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804
Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411
Self-citation
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386
Self-citation
Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry
Piccirillo, J. F. (2004) · JAMA · doi:10.1001/jama.291.20.2441 · Cited by 1,204
Can Comorbidity Be Measured By Questionnaire Rather than Medical Record Review?
Katz, J. N., Chang, L. C., SANGHA, O., Fossel, A. H., & Bates, D. W. (1996) · Medical Care · doi:10.1097/00005650-199601000-00006 · Cited by 1,035
Comorbidity and functional status are independent in older cancer patients.
Extermann, M., Overcash, J. A., Lyman, G. H., Parr, J., & Balducci, L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1582 · Cited by 986
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Sullivan, K. M., Agura, E. D., Anasetti, C., Appelbaum, F. R., Badger, C. C., Bearman, S. I., Erickson, K., Flowers, M. E. D., Hansen, J. A., & Loughran, T. P. (1991) · PubMed · Cited by 790
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
Kaplan, M. H., & Feinstein, A. R. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90017-4 · Cited by 668
Hematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
Gratwohl, A. A., Hermans, J., Goldman, J. M., Arcese, W., Carreras, E., Devergié, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D. W., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
Boeckh, M., Gooley, T. A., Myerson, D., Cunningham, T., Schoch, G. H., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 643
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
Marr, K. A., Seidel, K. D., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 510
Adapting the charlson comorbidity index for use in patients with ESRD
Hemmelgarn, B. R., Manns, B., Quan, H., & Ghali, W. A. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00415-3 · Cited by 496
Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies
Goldstein, L. B., Samsa, G. P., Matchar, D. B., & Horner, R. D. (2004) · Stroke · doi:10.1161/01.str.0000135225.80898.1c · Cited by 483
Measuring comorbidity in older cancer patients
Extermann, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00319-6 · Cited by 477
Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.
Yancik, R., Wesley, M. N., Ries, L., Havlik, R. J., Long, S., Edwards, B. K., & Yates, J. W. (1998) · PubMed · Cited by 408
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
Maloney, D. G., Molina, A. J., Sahebi, F., Stockerl-Goldstein, K. E., Sandmaier, B. M., Bensinger, W., Storer, B. E., Hegenbart, U., Somlo, G., Chauncey, T. R., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2955 · Cited by 403
Self-citation
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
Ra, C., Buckner, C. D., Thomas, E. D., Singer, J. W., Bowden, R. A., Bryant, E. M., Deeg, H. J., Doney, K., Fisher, L. D., & Hansen, J. (1994) · Blood · doi:10.1182/blood.v84.6.2036.2036 · Cited by 357
Clinical Approach to Infection in the Compromised Host
(1995) · Springer eBooks · doi:10.1007/978-1-4615-6642-7 · Cited by 337
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
Maris, M. B., Niederwieser, D. W., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Maloney, D. G., Petersdorf, E. W., McSweeney, P. A., Pulsipher, M. A., Woolfrey, A. E., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0482 · Cited by 334
Self-citation
Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning
Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M. L., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E. D., Mielcarek, M. B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.136 · Cited by 332
Self-citation
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Finkelstein, D. M., Ettinger, D. S., & Ruckdeschel, J. C. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.5.702 · Cited by 325
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
Diaconescu, R., Flowers, C. R., Storer, B. E., Sorror, M. L., Maris, M. B., Maloney, D. G., Sandmaier, B. M., & Storb, R. F. (2004) · Blood · doi:10.1182/blood-2004-03-0804 · Cited by 321
Self-citation
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
Sorror, M. L., Maris, M. B., Storer, B. E., Sandmaier, B. M., Diaconescu, R., Flowers, C. R., Maloney, D. G., & Storb, R. F. (2004) · Blood · doi:10.1182/blood-2004-02-0545 · Cited by 320
Self-citation
Measurement and impact of comorbidity in older cancer patients
Extermann, M. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00090-1 · Cited by 302
Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base
Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1147 · Cited by 283
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
Deeg, H. J., Storer, B. E., Slattery, J. T., Anasetti, C., Doney, K., Hansen, J. A., Kiem, H., Martin, P. J., Petersdorf, E. W., Radich, J. P., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0527 · Cited by 283
Self-citation
Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability
Rochon, P. A., Katz, J. N., MORROW, L. A., McGlinchey, R. E., Ahlquist, M. M., Sarkarati, M., & Minaker, K. L. (1996) · Medical Care · doi:10.1097/00005650-199611000-00004 · Cited by 269
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
Maris, M. B., Sandmaier, B. M., Storer, B. E., Chauncey, T. R., Stuart, M. J., Maziarz, R. T., Agura, E. D., Langston, A. A., Pulsipher, M. A., Storb, R. F., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2275 · Cited by 255
Self-citation
Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional Study
Singh, B., Bhaya, M. H., Stern, J., Roland, J. T., Zimbler, M. S., Rosenfeld, R. M., Har‐El, G., & Lucente, F. E. (1997) · The Laryngoscope · doi:10.1097/00005537-199711000-00009 · Cited by 251
Graft-Versus-Host Disease
Professor, H.-W. V. (2006) · Springer eBooks · doi:10.1007/3-540-27806-0_623 · Cited by 242
Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia
Sorror, M. L., Maris, M. B., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Hegenbart, U., Agura, E. D., Chauncey, T. R., Leis, J. F., Pulsipher, M. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.569 · Cited by 230
Self-citation
Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose
Oshida, M., Uno, K., Suzuki, M., Nagashima, T., Hashimoto, H., Yagata, H., Shishikura, T., IMAZEKI, K., & Nakajima, N. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11 · Cited by 228
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.
Loberiza, F., Rizzo, J. D., Bredeson, C., Antin, J., Horowitz, M. M., Weeks, J. C., & Lee, S. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.757 · Cited by 225
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease
Sachdev, M., Sun, J. L., Tsiatis, A. A., Nelson, C. L., Mark, D. B., & Jollis, J. G. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.031 · Cited by 204
Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies
Firat, S. Y., Byhardt, R. W., & Gore, E. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02939-5 · Cited by 197
Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients
Boeckh, M., Bowden, R. A., Gooley, T. A., Myerson, D., & Corey, L. (1999) · Blood · doi:10.1182/blood.v93.5.1781.405a39c_1781_1782 · Cited by 162
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients
Hogan, W. J., Maris, M. B., Storer, B. E., Sandmaier, B. M., Maloney, D. G., Schoch, H. G., Woolfrey, A. E., Shulman, H. M., Storb, R. F., & McDonald, G. B. (2003) · Blood · doi:10.1182/blood-2003-04-1311 · Cited by 156
Self-citation
Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data
Newschaffer, C. J., Bush, T. L., & Penberthy, L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00050-4 · Cited by 144
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle
Sutton, L., Chastang, C., Ribaud, P., Jouet, J. P., Kuentz, M., Attal, M., Reiffers, J. J., Tigaud, J., Rio, B., Dauriac, C., et al. (1996) · Blood · doi:10.1182/blood.v88.1.358.358 · Cited by 140
Charlson Comorbidity Index is a Predictor of Outcomes in Incident Hemodialysis Patients and Correlates with Phase Angle and Hospitalization
Iorio, B. R. D., Cillo, N., Círillo, M., & Santo, N. G. D. (2004) · The International Journal of Artificial Organs · doi:10.1177/039139880402700409 · Cited by 123
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Kanda, Y., Mineishi, S., Saito, T., Saito, A. M., Yamada, S., Ohnishi, M., Chizuka, A., Niiya, H., Suenaga, K., Nakai, K., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703214 · Cited by 107
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction
Fujimaki, K., Maruta, A., Yoshida, M., Sakai, R., Tanabe, J., Koharazawa, H., Kodama, F., Asahina, S., Minamizawa, M., Matsuzaki, M., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702783 · Cited by 95
Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
Feinstein, L. C., Sandmaier, B. M., Hegenbart, U., McSweeney, P. A., Maloney, D. G., Gooley, T. A., Maris, M. B., Chauncey, T. R., Bruno, B., Appelbaum, F. R., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04057.x · Cited by 93
Self-citation
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years
Cahn, J.-Y. Y., Labopin, M., Schattenberg, A. V. M. B., Reiffers, J. J., Willemze, R., Zittoun, R., Bacigalupo, A. P., Prentice, G., Gluckman, É., Hervé, P., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400573 · Cited by 62
The Impact of Comorbidity and Age on Survival with Laryngeal Cancer
Sabin, S. L., Rosenfeld, R. M., Sundaram, K., Har‐El, G., & Lucente, F. E. (1999) · Ear Nose & Throat Journal · doi:10.1177/014556139907800813 · Cited by 57
Predictors of Mortality in Outpatient Geriatric Evaluation and Management Clinic Patients
Keller, B. K., & POTTER, J. F. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.6.m246 · Cited by 53
Prognostic relevance of ‘early‐onset’ graft‐versus‐host disease following non‐myeloablative haematopoietic cell transplantation
Mielcarek, M. B., Burroughs, L. M., Leisenring, W. M., Diaconescu, R., Martin, P. J., Sandmaier, B. M., Maloney, D. G., Maris, M. B., Chauncey, T. R., Shizuru, J. A., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05458.x · Cited by 41
Self-citation
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: A Phase I/II trial
Demirer, T., Petersen, F. B., Appelbaum, F. R., Barnett, T., Sanders, J. E., Deeg, H. J., Storb, R. F., Doney, K., Bensinger, W., Shannon‐Dorcy, K., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00115-f · Cited by 40
Self-citation
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial
Gómez‐Núñez, M., Martino, R., Caballero, M. D., Pérez‐Simón, J. A., Canals, C., Mateos, M., Sarrà, J., León, A., Solano, C., Moraleda, J. M., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704379 · Cited by 39
Infection in Hematopoietic Stem Cell Transplantation
Boeckh, M., & Marr, K. A. (2002) · Springer eBooks · doi:10.1007/0-306-47527-8_16 · Cited by 34
Korreliert der Charlson-Comorbidity-Index mit dem postoperativen Verlauf bei Patienten mit Magenkarzinom?
Lübke, T., Mönig, S., Schneider, P. M., Hölscher, A., & Bollschweiler, E. (2003) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/s-2003-44805 · Cited by 25
Handbook of Bone Marrow Transplantation
Carella, A. M., Lazarus, H. M., & Rowe, J. M. (2000) · Medical Entomology and Zoology · Cited by 21
Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.
Mielcarek, M. B., Burroughs, L. M., Leisenring, W. M., Martin, P. J., Diaconezcu, R., Sandmaier, B. M., Maloney, D. G., Chauncey, T. R., Maris, M. B., Shizuru, J. A., et al. (2004) · Blood · doi:10.1182/blood.v104.11.423.423 · Cited by 9
Self-citation

Research works printed but not linked: 1

Lubke T, Monig SP, Schneider PM, Holscher AH, Bollschweiler E. Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer? [German]. Zentralblatt für Chirurgie.2003;128: 970-976.

Sorted by citations

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D. J., Larson, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,438
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., Dinardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,430
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,457
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S. R., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,491
Self-citation
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Armand, P. A., Kim, H. T., Logan, B. R., Wang, Z. P., Alyea, E. P., Kalaycio, M. E., Maziarz, R. T., Antin, J. H., Soiffer, R. J., Weisdorf, D. J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552984 · Cited by 951

See all 2,969

Authors: Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B.
Affiliations: University of Washington (US)
From the Fred Hutchinson Cancer Research Center, Seattle, WA; and the University of Washington, Seattle, WA.
ORCID: Sorror, Mohamed L.
Storb, Rainer
Sandmaier, Brenda M.
Maloney, David G.
Storer, Barry
Venue: Blood
Publisher: American Society of Hematology
Published: 2005-10-15
Volume: 106
Issue: 8
Pages: 2912-2919
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2005-05-2004
PMC: PMC1895304
OpenAlex: W2128812336
Cited by: 2,969
References: 62
Citations by year: 2026: 139 · 2025: 208 · 2024: 223 · 2023: 213 · 2022: 192 · 2021: 246 · 2020: 209 · 2019: 171 · 2018: 173 · 2017: 174 · 2016: 144 · 2015: 145 · 2014: 134 · 2013: 112 · 2012: 86
FWCI: 25.46
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
ORBi (University of Liège) (submittedVersion, other-oa)
Funders: Fred Hutchinson Cancer Research Center
University of Washington
National Heart, Lung, and Blood Institute (HL-36444, P01HL036444)
National Cancer Institute (CA 49605, CA18029, CA 15704+, K23CA092058, CA 78902, CA92058, P01CA049605, P30CA015704, P01CA018029, P01CA078902)
Topics: Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: hematopoietic stem cell transplantation, allogeneic transplantation, comorbidity index, Charlson Comorbidity Index, risk assessment, non-relapse mortality, survival prediction, prognostic scoring
MeSH terms: Contraindications, Adolescent, Adult, Aged, Cause of Death, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Prognosis, Transplantation, Homologous, Reproducibility of Results, Comorbidity, Survival Rate, Proportional Hazards Models, Treatment Outcome, Risk Assessment, Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks